Lise Lotte Gluud

This paper evaluates 11 EV isolation methods to determine their performance and applications, providing guidance on method selection based on downstream needs.

This paper identifies a four-protein proteomic signature that predicts progression to decompensated cirrhosis with high accuracy in both training and external validation cohorts.

This study evaluates Gremlin-1 as a therapeutic target in MASH fibrosis, finding it upregulated but not amenable to targeting due to its restricted expression and lack of effect on fibrogenesis.